Natera (NTRA) EBT Margin Growth (3y) (2017 - 2026)
Natera (NTRA) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | -211.00 |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 399.00 |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | -317.00 |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 4,440.00 |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 135.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | -2.00 |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 7.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,440.00 |
| Dec 31, 2025 | 6,343.00 |
| Sep 30, 2025 | 4,284.00 |
| Jun 30, 2025 | 5,472.00 |
| Mar 31, 2025 | 5,800.00 |
| Dec 31, 2024 | 6,968.00 |
| Sep 30, 2024 | 8,848.00 |
| Jun 30, 2024 | 7,268.00 |
| Mar 31, 2024 | 2,357.00 |
| Dec 31, 2023 | 4,294.00 |
| Sep 30, 2023 | 1,884.00 |
| Jun 30, 2023 | 2,645.00 |
| Mar 31, 2023 | -1,898.00 |
| Dec 31, 2022 | -2,315.00 |
| Sep 30, 2022 | -2,794.00 |
| Jun 30, 2022 | -3,209.00 |
| Mar 31, 2022 | -2,039.00 |
| Dec 31, 2021 | -3,369.00 |
| Sep 30, 2021 | -5,031.00 |
| Jun 30, 2021 | -2,807.00 |